HIV Cure Center at UNC to receive $26M in funding over 5 years
Date Published:
by Mark Derewicz
The National Institutes of Health has awarded approximately $53 million in annual funding over the next five…
Life Sciences
Durham life science firm BioAgilytix makes 2nd acquisition this week
Date Published:
BioAgilytix Labs is continuing to grow through acquisition, announcing Wednesday evening its second acquisition this week.
Joining the fast-growing life science…
Durham Tech to launch pharma workforce training program with $300,000 in grants
Date Published:
by Jim Shamp, NCBiotech Writer
Federal and local grants totaling $300,000 are enabling a new pharmaceutical manufacturing workforce training program…
Durham’s BioAgilytix Labs to buy Australian CRO
Date Published:
BioAgilytix Labs is acquiring an Australian-based contract research organization (CRO) as the company seeks to expand its global footprint, it announced Monday…
Producing the newest medicines – and potentially cures: gene and cell therapies
Date Published:
By Abbey Slattery
Gene and cell therapies are paving the way to breakthrough treatments and potential cures for serious illnesses…
Two NC pharma execs crack magazine’s ‘most inspiring’ list
Date Published:
by Barry Teater
Two North Carolina-based executives are among the 100 most inspiring leaders in the nation’s pharmaceutical industry, according…
Life science firm bioMerieux, SAS partner to tackle antimicrobial resistance
Date Published:
bioMérieux Inc., a world leader in in vitro diagnostic solutions for infectious disease, has partnered with global analytics leader SAS to help…
Precision medicine firm picks Durham for genomic sequencing lab, 200 jobs
Date Published:
by Jim Shamp, NCBiotech Writer
Tempus, a fast-growing artificial intelligence and precision medicine company, has established a new Durham lab,…
Inside Amgen’s decision to build new plant, create hundreds of jobs in Holly Springs
Date Published:
by Jim Shamp, NCBiotech Writer
Amgen Inc., a biopharmaceutical company that pioneered the use of recombinant DNA technology four decades ago…